Find results that contain all of your keywords. Content filter is on. Search will return stock photos and royalty free images.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Explore cartoons & images using related keywords:

pdb1s8b

cd20

cd

20

cluster

differentiation

blymphocyte

 lymphocyte bcell antigen ms4a1 surface lymphoma leukemia immunohistochemistry histology antibody rituximab obinutuzumab ibritumab tiuxetan veltuzumab lupus rheumatoid arthritis multiple sclerosis structure peptide protein amino acid molecule polypeptide polymer atoms science scientific disease health molecular model 3d rendering illustration dark background black transparent artistic

B-lymphocyte Antigen CD20 (theoretical Model). Protein Expressed On The Surface Of B-cells. Anti-CD20 Monoclonal Antibody Drugs Royalty-Free Stock Image


B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs Stock Photo
Download
Designed by
Title
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs #188464504
Description

B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs include rituximab, ibritumab tiuxetan, ofatumumab, obinutuzumab and tositumomab. 3D rendering based on protein data bank entry 1s8b. Cartoon representation combined with semi-transparent surfaces. Dark background

Humoral immunity. Lymphocyte, antibody and antigen
Humoral immunity. antibody-mediated immunity. Viruse, Lymphocyte, antibody and antigen. Vector diagram for educational, biological
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia

B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B cell lymphocyte
Lymphocyte basophil and mast cell
B cell lymphocyte